Tempus AI (NASDAQ:TEM) Stock Price Down 4.2% – Here’s What Happened

Tempus AI, Inc. (NASDAQ:TEM)’s share price dropped 4.2% during trading on Wednesday . The company traded as low as $63.78 and last traded at $63.9820. Approximately 2,057,659 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 5,666,156 shares. The stock had previously closed at $66.78.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on TEM shares. Guggenheim boosted their price target on Tempus AI from $80.00 to $95.00 and gave the company a “buy” rating in a report on Friday, September 26th. Canaccord Genuity Group cut their price objective on Tempus AI from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Monday, December 22nd. HC Wainwright decreased their target price on shares of Tempus AI from $98.00 to $89.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tempus AI in a report on Wednesday, October 8th. Finally, Cowen cut shares of Tempus AI from a “buy” rating to a “hold” rating in a research note on Tuesday, October 21st. Six analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $87.20.

Tempus AI Stock Down 3.4%

The business has a 50-day moving average of $69.04 and a 200 day moving average of $73.72. The company has a market capitalization of $11.47 billion, a PE ratio of -54.20 and a beta of 5.22. The company has a debt-to-equity ratio of 2.45, a current ratio of 3.28 and a quick ratio of 3.12.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. The business had revenue of $334.21 million for the quarter, compared to the consensus estimate of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The company’s revenue was up 84.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.46) EPS. Equities research analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insider Activity at Tempus AI

In other Tempus AI news, EVP Erik Phelps sold 1,302 shares of the stock in a transaction on Tuesday, December 16th. The shares were sold at an average price of $67.42, for a total transaction of $87,780.84. Following the completion of the transaction, the executive vice president owned 89,280 shares in the company, valued at $6,019,257.60. This trade represents a 1.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the business’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $63.99, for a total transaction of $10,638,337.50. Following the completion of the sale, the chief executive officer owned 8,974,783 shares in the company, valued at approximately $574,296,364.17. This trade represents a 1.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 932,832 shares of company stock valued at $71,184,024 over the last quarter. 26.27% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Tempus AI

Several large investors have recently modified their holdings of TEM. Cranbrook Wealth Management LLC purchased a new stake in shares of Tempus AI in the third quarter valued at $25,000. JPL Wealth Management LLC purchased a new stake in Tempus AI in the 3rd quarter worth about $26,000. GAMMA Investing LLC bought a new stake in Tempus AI in the third quarter worth about $28,000. Concord Wealth Partners lifted its stake in Tempus AI by 308.0% in the second quarter. Concord Wealth Partners now owns 408 shares of the company’s stock worth $26,000 after purchasing an additional 308 shares during the last quarter. Finally, Allworth Financial LP lifted its stake in Tempus AI by 5,000.0% in the second quarter. Allworth Financial LP now owns 459 shares of the company’s stock worth $29,000 after purchasing an additional 450 shares during the last quarter. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.